Logo-bi
Original Research

1. Synthesis of New Functionalized Citric Acid-based Dendrimers as Nanocarrier Agents for Drug Delivery
Hassan Namazi*, Sanaz Motamedi, Mina Namvari
Bioimpacts. 2011;1(1): 63-69. doi: 10.5681/bi.2011.009
PMCID: PMC3648942     PMID: 23678409     Scopus ID: 84876698090    
Article
PDF
XML
Cited By:
51
7
0
Original Research

2. Drug nanocarrier agents based on starch-g-amino acids
Hassan Namazi*, Elnaz Abdollahzadeh
Bioimpacts. 2018;8(2): 99-106. doi: 10.15171/bi.2018.12
PMCID: PMC6026521     PMID: 29977831     Scopus ID: 85048075763    
Article
PDF
Full Text
XML
Cited By:
11
2
11
Original Research

3. Carboxymethylcellulose/MOF-5/Graphene oxide bio-nanocomposite as antibacterial drug nanocarrier agent
Zahra Karimzadeh, Siamak Javanbakht, Hassan Namazi*
Bioimpacts. 2019;9(1): 5-13. doi: 10.15171/bi.2019.02
PMCID: PMC6378098     PMID: 30788255     Scopus ID: 85060437287    
Article
PDF
Full Text
XML
Cited By:
118
15
118
Carboxymethylcellulose/MOF-5/Graphene oxide bio-nanocomposite was synthesized through a solvothermal technique, which it could encapsulate tetracycline. The drug release tests showed the stability of drug dosing in the gastrointestinal tract conditions. Antibacterial tests exhibited suitable activity to negatively charge E. coli bacteria.
Editorial

4. Recent advances in targeted therapy of colorectal cancer: impacts of monoclonal antibodies nanoconjugates
Mostafa Akbarzadeh Khiavi ORCID, Azam Safary ORCID, Mohammad Hossein Somi* ORCID
Bioimpacts. 2019;9(3): 123-127. doi: 10.15171/bi.2019.16
PMCID: PMC6726747     PMID: 31508327     Scopus ID: 85071152476    
Article
PDF
Full Text
XML
Cited By:
23
9
23
Colorectal cancer (CRC) as a malignancy shows high mortality rate worldwide because of metastasis and drug resistance. Targeted multimodal nanosystems (NSs) can be developed and used against CRC with much better clinical outcomes.
Editorial

5. Targeted delivery of thrombolytic enzymes

Young M. Kwon* ORCID
BioImpacts. 2021;11(2): 85-86. doi: 10.34172/bi.2021.15
PMCID: PMC8022233     PMID: 33842278     Scopus ID: 85106598035    
Article
PDF
Full Text
XML
Cited By:
2
0
1
Young M. Kwon received his Ph.D. from University of Utah (USA) and his postdoctoral training at University of Michigan (USA). He is currently an Associate Professor of Pharmaceutical Sciences at Nova Southeastern University College of Pharmacy (USA). Dr. Kwon’s research interests include targeted delivery and controlled release of biological molecules.

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge